Boyle Scott N insider trades
Boyle Scott N has filed 12 Form 4s with the SEC that we hold, all for C4 Therapeutics, Inc. (CCCC), as Chief Business Officer. Across all of them we count 0 purchases worth $0 and 2 sales worth $3.7K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 669 shares of C4 Therapeutics, Inc. worth $2.1K, dated 2025-02-18. The first filing on our record is dated 2022-05-27 and the latest 2026-02-18.
C4 Therapeutics, Inc. (CCCC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-02-14 | S, sale reported on Form 4 | 490 | $1.5K | 2025-02-18 |
| 2025-02-18 | S, sale reported on Form 4 | 669 | $2.1K | 2025-02-18 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1913897) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms